5544 DAN DAN (Allopurinol 300 mg)
Pill with imprint 5544 DAN DAN is Orange, Round and has been identified as Allopurinol 300 mg. It is supplied by Watson Laboratories, Inc..
Allopurinol is used in the treatment of gout; calcium oxalate calculi with hyperuricosuria; heart failure; hyperuricemia secondary to chemotherapy; cardiothoracic surgery (and more), and belongs to the drug classes antigout agents, antihyperuricemic agents. Risk cannot be ruled out during pregnancy. Allopurinol 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 5544 DAN DAN
- 5544 DAN DAN
- 300 mg
- 11.00 mm
- Prescription only
- Drug Class:
- Antigout agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Laboratories, Inc.
- Inactive Ingredients:
- croscarmellose sodium
sodium lauryl sulfate
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
|NDC Code||Labeler / Repackager|
|62584-0713||Amerisource Health Services|
|54569-0235||A-S Medication Solutions, LLC (repackager)|
|63874-0755||Altura Pharmaceuticals Inc. (repackager)|
|54868-0076||Physicians Total Care Inc. (repackager)|
|67544-0313||Prepak Systems Inc. (repackager)|
More about allopurinol
- Allopurinol Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 56 Reviews – Add your own review/rating
- Drug class: antigout agents
- Allopurinol Tablets
- Allopurinol Injection
- Allopurinol (Advanced Reading)
- Allopurinol Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.